VIDEO: HOPE-3 trial expands scope of primary cardiovascular prevention

CHICAGO – The HOPE-3 trial has brought the primary prevention of cardiovascular disease front-and-center as a hot topic of discussion at the annual meeting of the American College of Cardiology....
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news